By Caroline McNeil  / 2016 National Cancer Policy Forum

Exploring the Opportunities and Challenges of Seamless Drug Development

The traditional three-phase clinical trial process for testing new drugs does not necessarily make sense when it comes to targeted therapies, according to many experts, including regulators, academic ...